A mathematical model for the transmission of Plasmodium vivax malaria.
We have proposed a mathematical model for the transmission of Plasmodium vivax malaria quantitatively, which is adjusted to the infected region, Guadalcanal, in the Solomon Islands. The simulation of a transmission model will be instrumental in planning the malaria control strategy. A characteristic of the life cycle of P. vivax is that a sporozoite injected into the blood stream by a mosquito bite may sometimes stay in a hepatocyte as a hypnozoite. Therefore, we have incorporated a phenomenon of renewed infections caused by a relapse into the transmission model. Also through the simulations we have attempted to evaluate the decline in prevalence caused by the programs of selective mass drug administration (MDA) and vector control such as the distribution of permethrin-treated bednets. The simulations have indicated that the concentrated repetition of MDA at 1-week intervals would reduce the prevalence of vivax malaria swiftly in the beginning and would keep the parasite rate below 1% for a few years but the prevalence would increase thereafter. In contrast, the parasite rate would remain below 1% for a long time if a trial of 1 or 2 times MDA is accompanied with some reduction of the vectorial capacity by the enforcement of vector control. In any case, it is important to beware of relapse cases because even after the execution of MDA it takes a long time to decrease the proportion of hypnozoite carriers.
Ishikawa
Hirofumi
H
Department of Environmental and Mathematical Sciences, Faculty of Environmental Science and Technology, Okayama University, Tsushimanaka, Okayama 700-8530, Japan. ishikawa@ems.okayama-u.ac.jp
Ishii
Akira
A
Nagai
Nobuhiko
N
Ohmae
Hiroshi
H
Harada
Masakazu
M
Suguri
Setsuo
S
Leafasia
Judson
J
D017677:Age Distribution; D000818:Animals; D002738:Chloroquine / Q000494:pharmacology; D003198:Computer Simulation; D007303:Insect Vectors; D016780:Malaria, Vivax / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission*; D015233:Models, Statistical; D008962:Models, Theoretical; D010966:Plasmodium vivax; D015995:Prevalence; D011319:Primaquine / Q000494:pharmacology
D002738:Chloroquine; D011319:Primaquine